CSL Limited

Aussie pharma stocks running long race to a COVID cure

Glenn Freeman
Glenn Freeman
Livewire Markets

Why do Australians pay crazy multiples for CSL?

Sam Byrnes
Sam Byrnes
ECP Asset Management

CSL Full Year Result: Bumper 2017 result but 2018 forecast underwhelms investors

CommSec
CommSec
Online Stockbroker

Investment foresight lifts CSL profit

Andrew Stanley
Andrew Stanley
Ralton Asset Management Limited

Australia’s Top 3 healthcare stocks

Intelligent Investor
Intelligent Investor
Independent Financial Research

CSL: Steady growth and diversified portfolio support underlying earnings

Scott Power
Scott Power
Morgans